Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Non-Current Debt (2022 - 2025)

Bio Key International's Non-Current Debt history spans 7 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Non-Current Debt rose 1091.88% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $1.0 million, up 1091.88%, while the annual FY2023 figure was $188787.0, 42.23% down from the prior year.
  • Non-Current Debt for Q3 2025 was $1.0 million at Bio Key International, up from $11666.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.0 million in Q3 2025 and bottomed at $11666.0 in Q1 2025.
  • The 4-year median for Non-Current Debt is $255219.0 (2023), against an average of $288843.2.
  • The largest YoY upside for Non-Current Debt was 1091.88% in 2025 against a maximum downside of 92.22% in 2025.
  • A 4-year view of Non-Current Debt shows it stood at $326767.0 in 2022, then crashed by 42.23% to $188787.0 in 2023, then plummeted by 55.56% to $83901.0 in 2024, then soared by 1091.88% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Non-Current Debt are $1.0 million (Q3 2025), $11666.0 (Q1 2025), and $83901.0 (Q3 2024).